BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 30095969)

  • 21. Acetaminophen-mediated cardioprotection via inhibition of the mitochondrial permeability transition pore-induced apoptotic pathway.
    Hadzimichalis NM; Baliga SS; Golfetti R; Jaques KM; Firestein BL; Merrill GF
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3348-55. PubMed ID: 17921323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preconditioning or Postconditioning with 8-Br-cAMP-AM Protects the Heart against Regional Ischemia and Reperfusion: A Role for Mitochondrial Permeability Transition.
    Khaliulin I; Ascione R; Maslov LN; Amal H; Suleiman MS
    Cells; 2021 May; 10(5):. PubMed ID: 34067674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melatonin Attenuates Cardiac Reperfusion Stress by Improving OPA1-Related Mitochondrial Fusion in a Yap-Hippo Pathway-Dependent Manner.
    Ma S; Dong Z
    J Cardiovasc Pharmacol; 2019 Jan; 73(1):27-39. PubMed ID: 30418242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetes impairs the protective effects of sevoflurane postconditioning in the myocardium subjected to ischemia/ reperfusion injury in rats: important role of Drp1.
    Yu J; He J; Yang W; Wang X; Shi G; Duan Y; Wang H; Han C
    BMC Cardiovasc Disord; 2021 Feb; 21(1):96. PubMed ID: 33593294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Sodium Thiosulfate Postconditioning on Ischemia-Reperfusion Injury Induced Mitochondrial Dysfunction in Rat Heart.
    Ravindran S; Kurian GA
    J Cardiovasc Transl Res; 2018 Jun; 11(3):246-258. PubMed ID: 29721767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of Hydrogen Sulfide Preconditioning-Associated Protection Against Ischemia-Reperfusion Injury Differs in Diabetic Heart That Develops Myopathy.
    Ansari M; Kurian GA
    Cardiovasc Toxicol; 2020 Apr; 20(2):155-167. PubMed ID: 31317389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vagus nerve stimulation exerts cardioprotection against myocardial ischemia/reperfusion injury predominantly through its efferent vagal fibers.
    Nuntaphum W; Pongkan W; Wongjaikam S; Thummasorn S; Tanajak P; Khamseekaew J; Intachai K; Chattipakorn SC; Chattipakorn N; Shinlapawittayatorn K
    Basic Res Cardiol; 2018 May; 113(4):22. PubMed ID: 29744667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sevoflurane as opposed to propofol anesthesia preserves mitochondrial function and alleviates myocardial ischemia/reperfusion injury.
    Lotz C; Stumpner J; Smul TM
    Biomed Pharmacother; 2020 Sep; 129():110417. PubMed ID: 32574972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Remifentanil Induces Cardio Protection Against Ischemia/Reperfusion Injury by Inhibiting Endoplasmic Reticulum Stress Through the Maintenance of Zinc Homeostasis.
    Sheng M; Zhang G; Wang J; Yang Q; Zhao H; Cheng X; Xu Z
    Anesth Analg; 2018 Jul; 127(1):267-276. PubMed ID: 29771714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular calcification abrogates the nicorandil mediated cardio-protection in ischemia reperfusion injury of rat heart.
    Ravindran S; Murali J; Amirthalingam SK; Gopalakrishnan S; Kurian GA
    Vascul Pharmacol; 2017 Feb; 89():31-38. PubMed ID: 28087358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydralazine protects the heart against acute ischaemia/reperfusion injury by inhibiting Drp1-mediated mitochondrial fission.
    Kalkhoran SB; Kriston-Vizi J; Hernandez-Resendiz S; Crespo-Avilan GE; Rosdah AA; Lees JG; Costa JRSD; Ling NXY; Holien JK; Samangouei P; Chinda K; Yap EP; Riquelme JA; Ketteler R; Yellon DM; Lim SY; Hausenloy DJ
    Cardiovasc Res; 2022 Jan; 118(1):282-294. PubMed ID: 33386841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effect of melatonin against mitochondrial dysfunction associated with cardiac ischemia- reperfusion: role of cardiolipin.
    Petrosillo G; Di Venosa N; Pistolese M; Casanova G; Tiravanti E; Colantuono G; Federici A; Paradies G; Ruggiero FM
    FASEB J; 2006 Feb; 20(2):269-76. PubMed ID: 16449799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mitochondrial permeability transition pore as a target of cardioprotective signaling.
    Baines CP
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H903-4. PubMed ID: 17513492
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of cytochrome c release by 10-N-nonyl acridine orange, a cardiolipin-specific dye, during myocardial ischemia-reperfusion in the rat.
    Zhang GX; Kimura S; Murao K; Obata K; Matsuyoshi H; Takaki M
    Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H433-9. PubMed ID: 19940077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acquired deficiency of tafazzin in the adult heart: Impact on mitochondrial function and response to cardiac injury.
    Szczepanek K; Allegood J; Aluri H; Hu Y; Chen Q; Lesnefsky EJ
    Biochim Biophys Acta; 2016 Apr; 1861(4):294-300. PubMed ID: 26692032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kaempferol protects cardiomyocytes against anoxia/reoxygenation injury via mitochondrial pathway mediated by SIRT1.
    Guo Z; Liao Z; Huang L; Liu D; Yin D; He M
    Eur J Pharmacol; 2015 Aug; 761():245-53. PubMed ID: 26086862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histamine H2 receptor activation exacerbates myocardial ischemia/reperfusion injury by disturbing mitochondrial and endothelial function.
    Luo T; Chen B; Zhao Z; He N; Zeng Z; Wu B; Fukushima Y; Dai M; Huang Q; Xu D; Bin J; Kitakaze M; Liao Y
    Basic Res Cardiol; 2013 May; 108(3):342. PubMed ID: 23467745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased mitochondrial calcium coexists with decreased reperfusion injury in postconditioned (but not preconditioned) hearts.
    Argaud L; Gateau-Roesch O; Augeul L; Couture-Lepetit E; Loufouat J; Gomez L; Robert D; Ovize M
    Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H386-91. PubMed ID: 17951363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitrite-Nitric Oxide Signaling and Cardioprotection.
    Totzeck M; Hendgen-Cotta UB; Rassaf T
    Adv Exp Med Biol; 2017; 982():335-346. PubMed ID: 28551796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigating and re-evaluating the role of glycogen synthase kinase 3 beta kinase as a molecular target for cardioprotection by using novel pharmacological inhibitors.
    Nikolaou PE; Boengler K; Efentakis P; Vouvogiannopoulou K; Zoga A; Gaboriaud-Kolar N; Myrianthopoulos V; Alexakos P; Kostomitsopoulos N; Rerras I; Tsantili-Kakoulidou A; Skaltsounis AL; Papapetropoulos A; Iliodromitis EK; Schulz R; Andreadou I
    Cardiovasc Res; 2019 Jun; 115(7):1228-1243. PubMed ID: 30843027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.